Title : Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator.

Pub. Date : 2021 Jan 1

PMID : 33049605






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator. Isoxazoles nuclear receptor subfamily 1, group H, member 4 Mus musculus
2 Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator. Isoxazoles nuclear receptor subfamily 1, group H, member 4 Mus musculus
3 Our efforts focusing on isoxazole-type FXR agonists, common nonsteroidal agonists for FXR, led to the discovery a series of novel FXR agonists bearing aryl urea moieties through structural simplification of LJN452 (phase 2). Isoxazoles nuclear receptor subfamily 1, group H, member 4 Mus musculus
4 Our efforts focusing on isoxazole-type FXR agonists, common nonsteroidal agonists for FXR, led to the discovery a series of novel FXR agonists bearing aryl urea moieties through structural simplification of LJN452 (phase 2). Isoxazoles nuclear receptor subfamily 1, group H, member 4 Mus musculus
5 Our efforts focusing on isoxazole-type FXR agonists, common nonsteroidal agonists for FXR, led to the discovery a series of novel FXR agonists bearing aryl urea moieties through structural simplification of LJN452 (phase 2). Isoxazoles nuclear receptor subfamily 1, group H, member 4 Mus musculus